NEXI-003 / NexImmune  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NEXI-003 / NexImmune
NCT05582590: Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

Not yet recruiting
1
36
NA
Fludarabine, Fludara, Cyclophosphamide, Cytoxan, NEXI-003 T cells
NexImmune Inc.
Oropharyngeal Cancer, Human Papilloma Virus, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Cancer, Metastatic, Head and Neck Cancer Metastatic, HPV-Related Squamous Cell Carcinoma, HPV-Related Mucosal Head and Neck Squamous Cell Carcinoma, Relapsed Oropharyngeal SCC, Refractory Oropharyngeal Squamous Cell Carcinoma
07/26
08/27

Download Options